Is the Advanced Cardiac Life Support Algorithm Always Correct? A Case of Catecholaminergic Polymorphic Ventricular Tachycardia

Authors

  • Nicole I Cillis Department of Internal Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157
  • George M Bodziock Cardiovascular Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157
  • Taylor S Ferris Department of Internal Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157
  • Nikhil Patel Cardiovascular Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157
  • Tejit V Pothuraju Department of Internal Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157
  • Prashant D Bhave Cardiovascular Medicine, Atrium Health Wake Forest Baptist Medical Center, One Medical Center Blvd, Winston Salem, NC 27157

DOI:

https://doi.org/10.14738/bjhmr.113.16959

Keywords:

Catecholaminergic polymorphic ventricular tachycardia, ventricular arrhythmia, electrical storm, ACLS

Abstract

A 19-year-old male with catecholaminergic polymorphic ventricular tachycardia (CPVT) presented with outside-of-hospital cardiac arrest in electrical storm. Ventricular arrhythmias persisted while following the Advanced Cardiac Life Support (ACLS) algorithm using epinephrine boluses. Upon deviation from the ACLS algorithm and use of beta blockers, ventricular arrhythmias ceased and patient was successfully stabilized. Treatment of CPVT electrical storm is challenging due to limited guidelines.  Antiarrhythmic agents such as beta blockers and flecainide are among the primary treatment options. This case report highlights a unique example of how deviation from traditional ACLS may be necessary to best treat CPVT storm.

References

Leenhardt A, Denjoy I, Guicheney P. Catecholaminergic Polymorphic Ventricular Tachycardia. Circ Arrhythm Electrophysiol. 2012;5(5):1044-1052. doi:10.1161/CIRCEP.111.962027

Kim CW, Aronow WS, Dutta T, Frenkel D, Frishman WH. Catecholaminergic Polymorphic Ventricular Tachycardia. Cardiol Rev. 2020;28(6):325-331. doi:10.1097/CRD.0000000000000302

Bergeman AT, Wilde AAM, van der Werf C. Catecholaminergic Polymorphic Ventricular Tachycardia: A Review of Therapeutic Strategies. Card Electrophysiol Clin. 2023;15(3):293-305. doi: 10.1016/j.ccep.2023.04.002

Priori SG, Napolitano C, Memmi M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106(1):69-74. doi: 10.1161/01.cir.0000020013. 73106.d8

Sumitomo N, Harada K, Nagashima M, et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart Br Card Soc. 2003;89(1):66-70. doi:10.1136/heart.89.1.66

van der Werf C, Kannankeril PJ, Sacher F, et al. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J Am Coll Cardiol. 2011;57(22):2244-2254. doi: 10.1016/j.jacc.2011.01.026

Watanabe H, van der Werf C, Roses-Noguer F, et al. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm. 2013;10(4):542-547. doi: 10.1016/j.hrthm.2012.12.035

Algorithms. cpr.heart.org. Accessed October 21, 2023. https://cpr.heart.org/en/resuscitation-science/cprand-ecc-guidelines/algorithms

Downloads

Published

2024-05-16

How to Cite

Cillis, N. I., Bodziock, G. M., Ferris, T. S., Patel, N., Pothuraju, T. V., & Bhave, P. D. (2024). Is the Advanced Cardiac Life Support Algorithm Always Correct? A Case of Catecholaminergic Polymorphic Ventricular Tachycardia . British Journal of Healthcare and Medical Research, 11(3), 73–78. https://doi.org/10.14738/bjhmr.113.16959